文献速递胸部介入CT

CT引导下经皮肺穿刺活检非诊断性结果预测模型的开发与外部验证

Development and external validation of a predictive model of nondiagnostic results in patients undergoing CT-guided percutaneous transthoracic needle lung biopsy.
PubMed 文献 · Br J Radiol · 2025-01-01

回顾性纳入训练队列954例和外部验证队列186例CT引导下经皮肺穿刺活检,构建预测非诊断性结果的列线图,含年龄、病灶大小、分叶征、空气支气管征、样本数和验前概率六个独立预测因子,训练与验证队列C统计量分别为0.752和0.734,并按低风险(<40%)与高风险(≥40%)分组给出取样建议。

要点

  • 模型含六个独立预测因子:活检时年龄、病灶大小、分叶征、空气支气管征、样本数、验前概率。
  • 训练队列非诊断性结果占280/954(29.4%),训练与外部验证C统计量分别为0.752和0.734。
  • 按非诊断性结果概率分低风险(<40%)与高风险(≥40%)两组,各组取样建议不同。

核心结论

  • 列线图在预测肺穿刺活检非诊断性结果方面表现良好,针对各风险组给出的建议可能有助于临床实践。

研究设计与样本

  • 回顾性纳入训练队列954例PTNB和外部验证队列186例PTNB,结果分为诊断性或非诊断性,采用逻辑回归筛选独立预测因子,以C统计量、校准曲线和决策曲线分析分别评价区分度、校准度和临床实用性。

诊断标准与关键数值

  • 模型纳入六个独立预测因子:活检时年龄、病灶大小、分叶征、空气支气管征、样本数、验前概率;训练队列C统计量0.752,外部验证队列0.734;按非诊断性结果概率分低风险(<40%)和高风险(≥40%)两组。

临床应用与阅片要点

  • 对低风险且样本数≤2的病灶,应获取≤2个样本;对低风险且样本数≥3的病灶,适当时应获取更多样本;对高风险且样本数≥3的病灶,需重新考虑PTNB。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop and validate a nomogram to predict nondiagnostic results in patients undergoing CT-guided percutaneous transthoracic needle biopsy (PTNB) of the lung.

METHODS: A total of 954 PTNBs in the training cohort and 186 PTNBs in the external validation cohort were retrospectively included. PTNB results were categorized as diagnostic or nondiagnostic. Logistic regression was used to identify independent predictors of nondiagnostic results. C-statistic, calibration curve, and decision curve analysis were used to evaluate discrimination, calibration, and clinical usefulness, respectively.

RESULTS: Of 954 PTNBs in the training cohort, 280 (29.4%) were nondiagnostic results. The model included six independent predictors: age at biopsy, lesion size, lobulation sign, air bronchogram, the number of samples, and pre-test probability. The C-statistics for the training and external validation cohorts were 0.752 and 0.734, respectively. Two risk groups were identified with low (<40%) and high (≥40%) probabilities of nondiagnostic results. For lesions of low risk with the number of samples ≤ 2, ≤2 samples should be obtained; for lesions of low risk with the number of samples ≥3, more samples should be obtained when appropriate; for lesions of high risk with the number of samples ≥3, PTNB needs to be reconsidered.

CONCLUSIONS: The nomogram showed good performance in predicting the nondiagnostic results of PTNB of the lung. Suggestions for each risk group may facilitate clinical practice.

ADVANCES IN KNOWLEDGE: Pretest probability was a significant factor to predict nondiagnostic results of PTNB. The number of samples of PTNB should be different for different risk groups to avoid nondiagnostic results.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Du Y, Yang L, Zhang X, et al. Development and external validation of a predictive model of nondiagnostic results in patients undergoing CT-guided percutaneous transthoracic needle lung biopsy. Br J Radiol. 2025. PMID: 40419937. doi:10.1093/bjr/tqaf110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。